IL46613A - Substituted 4-benzylpiperidino alkanone,slkanoneoxime and alkanol derivatives - Google Patents

Substituted 4-benzylpiperidino alkanone,slkanoneoxime and alkanol derivatives

Info

Publication number
IL46613A
IL46613A IL46613A IL4661375A IL46613A IL 46613 A IL46613 A IL 46613A IL 46613 A IL46613 A IL 46613A IL 4661375 A IL4661375 A IL 4661375A IL 46613 A IL46613 A IL 46613A
Authority
IL
Israel
Prior art keywords
slkanoneoxime
benzylpiperidino
alkanone
substituted
alkanol derivatives
Prior art date
Application number
IL46613A
Other languages
English (en)
Other versions
IL46613A0 (en
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of IL46613A0 publication Critical patent/IL46613A0/xx
Publication of IL46613A publication Critical patent/IL46613A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
IL46613A 1974-03-04 1975-02-11 Substituted 4-benzylpiperidino alkanone,slkanoneoxime and alkanol derivatives IL46613A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/447,926 US3946022A (en) 1974-03-04 1974-03-04 Piperidine derivatives

Publications (2)

Publication Number Publication Date
IL46613A0 IL46613A0 (en) 1975-04-25
IL46613A true IL46613A (en) 1979-09-30

Family

ID=23778297

Family Applications (1)

Application Number Title Priority Date Filing Date
IL46613A IL46613A (en) 1974-03-04 1975-02-11 Substituted 4-benzylpiperidino alkanone,slkanoneoxime and alkanol derivatives

Country Status (16)

Country Link
US (1) US3946022A (nl)
JP (1) JPS50117780A (nl)
BE (1) BE826012A (nl)
CA (1) CA1053678A (nl)
CH (1) CH610888A5 (nl)
DE (1) DE2506770A1 (nl)
DK (2) DK84375A (nl)
ES (1) ES435246A1 (nl)
FR (1) FR2262986B1 (nl)
GB (1) GB1442118A (nl)
IE (1) IE40598B1 (nl)
IL (1) IL46613A (nl)
NL (1) NL7502157A (nl)
NO (1) NO144455C (nl)
SE (1) SE7502298L (nl)
ZA (1) ZA75894B (nl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035372A (en) * 1976-08-13 1977-07-12 G. D. Searle & Co. 4-{[4-(Diphenylmethyl)-1-piperidinyl]methyl}benzenamines
US4163790A (en) * 1977-05-11 1979-08-07 A. H. Robins Company, Inc. Method for increasing coronary blood flow in mammals
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4370335A (en) * 1982-02-02 1983-01-25 Mcneilab, Inc. Antisecretory 4-diphenylmethyl-1-[(oxoalkyl)imino]methyl-piperidines and their derivatives
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체
DE3917241A1 (de) * 1989-05-26 1990-11-29 Schaper & Bruemmer Gmbh 4-(hydroxydiphenylmethyl)-1-piperidyl-phenylalkan-derivate
CA2166100A1 (en) * 1993-06-23 1995-01-05 Richard A. Glennon Sigma receptor ligands and the use thereof
AU670004B2 (en) 1993-06-24 1996-06-27 Albany Molecular Research, Inc. Piperidine derivatives and process for their production
US20020007068A1 (en) * 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
CA2362339C (en) 1993-06-25 2005-08-02 Merrell Pharmaceuticals Inc. Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6372712B1 (en) 1998-05-22 2002-04-16 The Board Of Trustees Of The Leland Stanford Jr. University Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CN100390146C (zh) * 2002-11-13 2008-05-28 斯索恩有限公司 制备利培酮的方法和用于该方法的中间体
PT1889198E (pt) 2005-04-28 2015-03-06 Proteus Digital Health Inc Sistema fármaco-informático
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
NZ596876A (en) 2009-05-06 2014-01-31 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
BE794596A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Piperidinoalcanone-oximes substituees et leur procede de preparation

Also Published As

Publication number Publication date
NO144455C (no) 1981-09-02
DK84375A (nl) 1975-09-05
FR2262986B1 (nl) 1980-02-22
ES435246A1 (es) 1976-12-16
US3946022A (en) 1976-03-23
SE7502298L (nl) 1975-09-05
NL7502157A (nl) 1975-09-08
AU7808475A (en) 1976-08-12
FR2262986A1 (nl) 1975-10-03
IL46613A0 (en) 1975-04-25
IE40598B1 (en) 1979-07-04
GB1442118A (en) 1976-07-07
IE40598L (en) 1975-09-04
JPS50117780A (nl) 1975-09-16
NO750698L (nl) 1975-09-05
CA1053678A (en) 1979-05-01
DE2506770A1 (de) 1975-09-11
CH610888A5 (nl) 1979-05-15
DK393279A (da) 1979-09-20
NO144455B (no) 1981-05-25
ZA75894B (en) 1976-01-28
BE826012A (fr) 1975-06-16

Similar Documents

Publication Publication Date Title
IL46613A (en) Substituted 4-benzylpiperidino alkanone,slkanoneoxime and alkanol derivatives
CA1033605A (en) Photothermographic element, composition and process
JPS5165841A (en) Handotairandamu akusesu memori
CA1027409A (en) Photothermographic element, composition and process
IE41662L (en) Androstane derivatives.
GB1517973A (en) 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
JPS5178643A (en) Sabuchaneru memori akusesuseigyohoshiki
PH13133A (en) 8,8-disubstituted-6-methylergolines and related compounds
ZA754042B (en) 9-thia- or oxothia and dioxothia-11,12-seco-prostaglandin
PH12712A (en) Substituted s-alkylphenylisotrioureas,and their use as medicaments
AU521392B2 (en) 17-alpha-ethynyl-(5-alpha)-2-androsten-17-beta-ol and its beta-acetate
KE2924A (en) 2,3-dioyopiperazine derivatives
GB1487457A (en) 5,7-dihydroxy-tetraisoquinoline derivatives
IE41448L (en) Sedative method and compositions.
IL48365A0 (en) 10,11-dihydro-3-carboxycyproheptadine and its n-oxide
ZA752472B (en) 3,4-dicarboxycephalosporins and derivatives
EG12408A (en) O,s-dialkyl o-sulfonyloxyphenyl phosphoro-thiolates and phosphorodithiates
ZA757068B (en) 10,11-dihydro-3-carboxycyproheptadine and its n-oxide
PH11939A (en) 5,6-dibenzyloxy-2-aminotetralol derivatives
JPS5183742A (en) Randamu akusesu memori
JPS5165857A (en) Kondensa memori
MY7800024A (en) (alpha), (alpha)-disubstituted benzyl alcohols and derivatives thereof
AU488539B2 (en) 3, 4-dicarboxycephalosporins and derivatives
AU8221675A (en) 9-thia, 9-oxothia-, and 9-dioxothia-11,12-seco-prostaglandins
AU489490B2 (en) I. anesthetic COMPOSITION AND METHOD